Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
doi: 10.3389/FENDO.2019.00155/XML/NLM 6 ZhaoXWangMWenZLuZCuiLFuCet al
*Correspondence: Juan Huang, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Retatrutide administered once weekly subcutaneously for 12 weeks resulted in a dose-dependent placebo-adjusted weight loss of up to 8.96 kg in the highest dose group and a placebo-adjusted HbA1c reduction of up to 1.6% in a phase II trial in individuals with T2DM [125]
These medications could be really important, however, we just dont have that data yet.
US$ 27.23
US$ 24.25
US$ 24.32
US$ 27.15
